GNMX

Aevi Genomic Medicine, Inc.
GNMX

Overview Fund Activity
Delisted

GNMX was delisted on the 3rd of February, 2020.

Back to rankings

76 hedge funds and large institutions have $88.1M invested in Aevi Genomic Medicine, Inc. in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 6 closing their positions.

Holders
76
Holders Change
+8
Holders Change %
+11.76%
% of All Funds
1.9%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
25
Reduced
15
Closed
6
Calls
$6.58M
Puts
$337K
Net Calls
+$6.24M
Net Calls Change
+$5.86M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$1.88M
2
BFA
2
BlackRock Fund Advisors
California
$4.59M
3
Morgan Stanley
3
Morgan Stanley
New York
$440K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$5.99M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$357K

Top Sellers

1
OM
1
Opaleye Management
Massachusetts
$7.77M
2
QF
2
QVT Financial
New York
$0
3
SS
3
Sunbelt Securities
Texas
$0
4
TD Asset Management
4
TD Asset Management
Ontario, Canada
$0
5
BFM
5
Boothbay Fund Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
QF
76
QVT Financial
New York
– -$688K -123,500 Closed
SS
77
Sunbelt Securities
Texas
– -$223K -40,000 Closed
TD Asset Management
78
TD Asset Management
Ontario, Canada
– -$203K -36,500 Closed
BFM
79
Boothbay Fund Management
New York
– -$84K -15,170 Closed
CG
80
Cutler Group
California
– -$36K -6,614 Closed
BNP Paribas Financial Markets
81
BNP Paribas Financial Markets
France
– -$10.2K -1,824 Closed
1 2 3
4